Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Study to Compare CDB-2914 and Levonorgestrel-275993303
New England Medical Center
Search grants from New England Medical Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administration Core
Core B - Specimen Database.
Comprehensive Assessment of Pulmonary Disorders Using Polarized 13C Technology
The role of the GPI anchor in Cripto signaling and forebrain specification
Commutation Relations for SLE in Multiply Connected Domains and the Coupling Technique
Recently added grants:
The UCLA HIV/AIDS, Substance Abuse, and Trauma Training Program
Real-time Predictors of Prescription Drug Misuse by College Students and Assessment of Misuse on Their Developmental Trajectories
Mentalizing deficits in cocaine addiction, associations with immune dysregulation and childhood maltreatment
Non-opiate treatment after prenatal opiate exposure to Prevent Postnatal Injury to the Young Brain (No-POPPY)
Individualized assays of supra-threshold hearing deficits
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD093303-009
Application #
6829065
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
New England Medical Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel-275993303
/ New England Medical Center
NIH 2002
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel-275993303
/ New England Medical Center
NIH 1999
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel
Kennison, Robert F. / Tufts University
Comments
Be the first to comment on this grant